Literature DB >> 16978852

Spasmolytic and tonic effect of Iberogast (STW 5) in intestinal smooth muscle.

H P T Ammon1, O Kelber, S N Okpanyi.   

Abstract

STW 5 (Iberogast) is a fixed combination of nine medicinal plant extracts effective in the treatment of functional dyspepsia and irritable bowel syndrome. The effects of STW 5, a combination of Iberis amara fresh plant extract, and other eight plant extracts as well as single extract components including extracts from Menthae piperitae folium, Matricariae flos and Liquiritiae radix, were assayed in guinea pig ileum with or without stimulation with acetylcholine or histamine, in order to find a possible effect on the contractility of intestinal smooth muscle. STW 5 decreased acetylcholine- and histamine-induced contraction of guinea pig ileum. This was also true for extracts of Menthae piperitae folium, Matricariae flos and L. radix. Extract from I. amara, however, showed no spasmolytic action; in contrary, it increased the basal resting tone and contraction of atonic ileal segments. This was also true when STW 5 was employed. A spasmolytic action of STW 5 could also be observed in duodenum, jejunum and colon. These data are the first to show not only the spasmolytic effects of STW 5 and its component extracts in intestinal muscle but also the tonicising effects of STW 5 through its component Iberis amara extract in relaxed intestinal muscle. Thus, pharmacological evidence suggests a dual-action principle and may explain, at least in part, the clinically observed therapeutic efficacy of STW 5 (Iberogast) in both hypotonic and spastic dysmotility symptoms of functional dyspepsia and irritable bowel syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16978852     DOI: 10.1016/j.phymed.2006.08.004

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  16 in total

1.  Adenosine A2A receptor contributes to the anti-inflammatory effect of the fixed herbal combination STW 5 (Iberogast®) in rat small intestinal preparations.

Authors:  Sebastian Michael; Heba Abdel-Aziz; Dieter Weiser; Christa E Müller; Olaf Kelber; Karen Nieber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-12-10       Impact factor: 3.000

Review 2.  Herbal medicines for the management of irritable bowel syndrome: a comprehensive review.

Authors:  Roja Rahimi; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2012-02-21       Impact factor: 5.742

Review 3.  The use of non-narcotic pain medication in pediatric gastroenterology.

Authors:  Adrian Miranda; Miguel Saps
Journal:  Paediatr Drugs       Date:  2014-08       Impact factor: 3.022

Review 4.  Management Options for Irritable Bowel Syndrome.

Authors:  Michael Camilleri
Journal:  Mayo Clin Proc       Date:  2018-12       Impact factor: 7.616

Review 5.  Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.

Authors:  Diego Currò; Gianluca Ianiro; Silvia Pecere; Stefano Bibbò; Giovanni Cammarota
Journal:  Br J Pharmacol       Date:  2016-10-25       Impact factor: 8.739

Review 6.  [STW 5/Iberogast: multi-target-action for treatment of functional dyspepsia and irritable bowel syndrome].

Authors:  Hans-Dieter Allescher; Hildebert Wagner
Journal:  Wien Med Wochenschr       Date:  2007

7.  Drug management of visceral pain: concepts from basic research.

Authors:  Mellar P Davis
Journal:  Pain Res Treat       Date:  2012-04-24

8.  The Pharmacological Effects of Benachio-F(®) on Rat Gastrointestinal Functions.

Authors:  Bijay Kumar Poudel; Jae Young Yu; Yong Sam Kwon; Hyoung Geun Park; Miwon Son; Joon Ho Jun; Jeong Ah Kim; Jong Oh Kim
Journal:  Biomol Ther (Seoul)       Date:  2015-07-01       Impact factor: 4.634

9.  STW 5 is effective in dextran sulfate sodium-induced colitis in rats.

Authors:  Walaa Wadie; Heba Abdel-Aziz; Hala F Zaki; Olaf Kelber; Dieter Weiser; Mohamed T Khayyal
Journal:  Int J Colorectal Dis       Date:  2012-05-06       Impact factor: 2.571

10.  Phytotherapy of chronic abdominal pain following pancreatic carcinoma surgery: a single case observation.

Authors:  Karl Rüdiger Wiebelitz; André-Michael Beer
Journal:  Int J Gen Med       Date:  2012-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.